Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 23224 | 298 | 39.8 | 73% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | SPECIALTY CARE SERV | Address | 1 | 16% | 2% | 6 |
| 2 | PULM CRIT CARE MEDMED | Address | 1 | 40% | 1% | 2 |
| 3 | ANTIPLASMINS | Author keyword | 1 | 50% | 0% | 1 |
| 4 | FIBRINOGEN DEFICIENT MICE | Author keyword | 1 | 50% | 0% | 1 |
| 5 | FIBRINOLYSINS | Author keyword | 1 | 50% | 0% | 1 |
| 6 | JHMHC PEDIAT | Address | 1 | 50% | 0% | 1 |
| 7 | KLIN PRACOVNEHO LEKARSTVA KLIN TOXIKOL | Address | 1 | 50% | 0% | 1 |
| 8 | MYELOID DIFFERENTIATION PROTEIN MD 2 | Author keyword | 1 | 50% | 0% | 1 |
| 9 | TRIALS SAFETY BRANCH | Address | 1 | 50% | 0% | 1 |
| 10 | UBC MCDONALD | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ANTIPLASMINS | 1 | 50% | 0% | 1 | Search ANTIPLASMINS | Search ANTIPLASMINS |
| 2 | FIBRINOGEN DEFICIENT MICE | 1 | 50% | 0% | 1 | Search FIBRINOGEN+DEFICIENT+MICE | Search FIBRINOGEN+DEFICIENT+MICE |
| 3 | FIBRINOLYSINS | 1 | 50% | 0% | 1 | Search FIBRINOLYSINS | Search FIBRINOLYSINS |
| 4 | MYELOID DIFFERENTIATION PROTEIN MD 2 | 1 | 50% | 0% | 1 | Search MYELOID+DIFFERENTIATION+PROTEIN+MD+2 | Search MYELOID+DIFFERENTIATION+PROTEIN+MD+2 |
| 5 | DRUG OUTPUT | 0 | 33% | 0% | 1 | Search DRUG+OUTPUT | Search DRUG+OUTPUT |
| 6 | FIBRINOGEN DEGRADATION PRODUCT | 0 | 33% | 0% | 1 | Search FIBRINOGEN+DEGRADATION+PRODUCT | Search FIBRINOGEN+DEGRADATION+PRODUCT |
| 7 | PATHOGENSIS | 0 | 33% | 0% | 1 | Search PATHOGENSIS | Search PATHOGENSIS |
| 8 | PLASMIN SYSTEM | 0 | 15% | 1% | 2 | Search PLASMIN+SYSTEM | Search PLASMIN+SYSTEM |
| 9 | ALVEOLAR EPITHELIAL REPAIR | 0 | 25% | 0% | 1 | Search ALVEOLAR+EPITHELIAL+REPAIR | Search ALVEOLAR+EPITHELIAL+REPAIR |
| 10 | FIBRINOLYTIC COMPONENTS | 0 | 25% | 0% | 1 | Search FIBRINOLYTIC+COMPONENTS | Search FIBRINOLYTIC+COMPONENTS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LOCAL ABNORMALITIES | 10 | 47% | 5% | 16 |
| 2 | ALVEOLAR FIBRIN DEPOSITION | 6 | 42% | 4% | 11 |
| 3 | FIBRIN TURNOVER | 6 | 35% | 5% | 14 |
| 4 | FIBRINOLYTIC PATHWAYS | 2 | 67% | 1% | 2 |
| 5 | 4G 5G | 2 | 43% | 1% | 3 |
| 6 | ALVEOLAR FIBRIN FORMATION | 1 | 100% | 1% | 2 |
| 7 | BIOPHYSICAL INHIBITION | 1 | 33% | 1% | 2 |
| 8 | PLASMINOGEN ACTIVATOR GENES | 1 | 50% | 0% | 1 |
| 9 | TYPE 1 DEFICIENCY | 1 | 50% | 0% | 1 |
| 10 | JNK MEDIATED PATHWAY | 1 | 29% | 1% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The plasminogen activation system in lung disease | 2007 | 18 | 171 | 26% |
| The role of urokinase in idiopathic pulmonary fibrosis and implication for therapy | 2008 | 10 | 78 | 28% |
| Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis | 2008 | 46 | 236 | 11% |
| Idiopathic pulmonary fibrosis - a disorder of alveolar wound repair? | 2003 | 37 | 52 | 21% |
| Plasminogen activator inhibitor-1 in the pathogenesis of asthma | 2004 | 41 | 99 | 11% |
| The plasmin system in airway remodeling | 2003 | 68 | 81 | 9% |
| The Inflammatory Actions of Coagulant and Fibrinolytic Proteases in Disease | 2015 | 0 | 110 | 14% |
| Pathophysiology of acute lung injury | 2001 | 20 | 89 | 9% |
| ROLE OF ENZYMES MEDIATING THROMBOSIS AND THROMBOLYSIS IN LUNG-DISEASE | 1988 | 59 | 61 | 13% |
| Mechanisms of repair and remodeling following acute lung injury | 2000 | 24 | 228 | 9% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SPECIALTY CARE SERV | 1 | 16% | 2.0% | 6 |
| 2 | PULM CRIT CARE MEDMED | 1 | 40% | 0.7% | 2 |
| 3 | JHMHC PEDIAT | 1 | 50% | 0.3% | 1 |
| 4 | KLIN PRACOVNEHO LEKARSTVA KLIN TOXIKOL | 1 | 50% | 0.3% | 1 |
| 5 | TRIALS SAFETY BRANCH | 1 | 50% | 0.3% | 1 |
| 6 | UBC MCDONALD | 1 | 50% | 0.3% | 1 |
| 7 | C 6 | 0 | 33% | 0.3% | 1 |
| 8 | HLTH SCI MOLEC BIOL | 0 | 33% | 0.3% | 1 |
| 9 | PATHOL PULM CRIT CARE MED | 0 | 33% | 0.3% | 1 |
| 10 | ENVIRONM DIS TOXICOL | 0 | 25% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000139819 | MEGSIN//SERPINB2//PAI 2 |
| 2 | 0.0000119876 | ACTIVATED PROTEIN C//ENDOTHELIAL PROTEIN C RECEPTOR//DROTRECOGIN ALFA ACTIVATED |
| 3 | 0.0000114308 | UROKINASE RECEPTOR//UPAR//UPA |
| 4 | 0.0000113278 | 2 2 HYDROXYPROPANAMIDO BENZOIC ACID//2 5 DISUBSTITUTED DIOXACYCLOALKANES//PEPTIDE 6A |
| 5 | 0.0000095200 | BLEOMYCIN//PULMONARY FIBROSIS//LUNG FIBROSIS |
| 6 | 0.0000095074 | AFFLUENT YOUTH//BATTLEFIELD TRAUMA//DEV CLIN PSYCHOL PROGRAM |
| 7 | 0.0000091897 | AMIDOLYSIS//ELASTASE ALPHA1 PROTEINASE INHIBITOR//CLOT LYSIS ASSAY |
| 8 | 0.0000090212 | PLASMINOGEN ACTIVATOR INHIBITOR 1//PAI 1//FIBRINOLYSIS |
| 9 | 0.0000087498 | PLASTIC BRONCHITIS//BRONCHIAL CASTS//CAST BRONCHITIS |
| 10 | 0.0000076964 | TISSUE FACTOR//TISSUE FACTOR PATHWAY INHIBITOR//TFPI |